SomnoMed is a publicly traded company (ASX:SOM) founded in 2004 in Sydney, Australia. The North American office, located in Plano, Texas was opened in 2006; introducing their leading device technology to patients in America. To date there have been over 550,000 patients around the world who have been treated with SomnoDent therapy.
As the global leader in COAT (Continuous Open Airway Therapy) SomnoMed provides clinically proven diagnostic and treatment options for sleep-related breathing disorders such as obstructive sleep apnea (OSA) and sleep bruxism.
Visit www.somnomed.com for more information or to find obstructive sleep apnea (OSA) treatment today.
SomnoMed provides treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent® becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea (OSA). More than 550,000 patients around the world have treated their mild to moderate obstructive sleep apnea (OSA) with SomnoDent oral device therapy. Worn during sleep and fitted by a dental sleep specialist, the SomnoDent line of oral appliances are customized to offer superior comfort and quality to each individual patient.
At SomnoMed, we keep the patient at the center of our focus and know that successful treatment is much more than just the device. With our history of innovation, commitment to connecting physicians and dentists, SomnoMed provides patients with the products and services they need to return to enjoying their lives.
SomnoMed is a publicly traded company (ASX:SOM) founded in 2004 in Sydney, Australia. The North American office, located in Frisco, Texas was opened in 2006.
As the global leader in COAT (Continuous Open Airway Therapy) SomnoMed provides clinically proven diagnostic and treatment options for sleep-related breathing disorders such as obstructive sleep apnea (OSA) and sleep bruxism.
Visit www.somnomed.com for more information or to find obstructive sleep apnea (OSA) treatment today.
SomnoMed provides treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent® becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea (OSA). More than 550,000 patients around the world have treated their mild to moderate obstructive sleep apnea (OSA) with SomnoDent oral device therapy. Worn during sleep and fitted by a dental sleep specialist, the SomnoDent line of oral appliances are customized to offer superior comfort and quality to each individual patient.
At SomnoMed, we keep the patient at the center of our focus and know that successful treatment is much more than just the device. With our history of innovation, commitment to connecting physicians and dentists, SomnoMed provides patients with the products and services they need to return to enjoying their lives.
SomnoMed is a publicly traded company (ASX:SOM) founded in 2004 in Sydney, Australia. The North American office, located in Frisco, Texas was opened in 2006.
Location: United States, Texas, Plano
Employees: 51-200
Phone: +1 888-447-6673
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | Kestrel Ca... | kestrelcap... |
Mentions in press and media 6
| Date | Title | Description |
| 29.11.2024 | Microbio Appoints Paul Brennan as Chair of the Board | BRISBANE, Australia, Nov. 29, 2024 /PRNewswire/ -- Microbio Ltd, the Australian pathogen diagnostics company specialising in innovative molecular diagnostic solutions, has appointed Paul Brennan as Chair of the Board, effective 2nd December... |
| 15.03.2024 | It's World Sleep Day, and these startups want to help you get better shut-eye | It's World Sleep Day, and I'm sure I'm not the only one feeling tired. I'm fortunate enough to get treatment from a sleep doctor, but I know most people face months-long waiting lists to access services. Women are more likely to be underdia... |
| 15.06.2023 | SomnoMed North America Partners with Nexus Dental Systems to Improve Access to Oral Appliance Therapy for OSA Patients in Federal and Commercial Market Segments | SomnoMed is on a mission to help as many people as possible who are suffering from mild to moderate OSA and the Nexus-trained offices offer greater access for patients while facilitating predictable reimbursement, so the choice was clear. P... |
| 31.05.2023 | Nexus Dental Systems Launches National HBCU Sleep Apnea Initiative at Grambling State University | "Grambling State is only the first stop on a national tour to bring needed care to an underserved community,” says Nexus Spokesperson and NFL Hall of Famer, Mel Blount. GRAMBLING, La. (PRWEB) May 31, 2023 Nexus Dental Systems (Nexus) l... |
| 28.10.2022 | SomnoMed's North America Q1 revenue growth leads the way | PLANO, Texas, Oct. 28, 2022 /PRNewswire/ -- SomnoMed Limited (ASX "SOM", or the Company), a leading company in the provision of oral appliance treatment solutions for sleep-related breathing disorders and obstructive sleep apnea (... |
| 24.06.2014 | Domobio’s QT33 Can Dramatically Improve Sleep Apnea Patients’ Quality Of Life | More than 18 million Americans have sleep apnea, a condition that affects their breathing while they are asleep. Not only does sleep apnea impact their sleep quality, but it can also increase the risk of strokes, heart attacks, congestive h... |